Information Provided By:
Fly News Breaks for December 15, 2015
SHPG, BXLT
Dec 15, 2015 | 08:06 EDT
Cowen said shares of Baxalta remain undervalued at current levels, citing the company's hemophilia and IG businesses, durable assets that should provide sustainable top-line growth over the next five years and a pipeline of products that should continue to deliver outperformance. Cowen reiterated its Outperform rating and $43 price target on Baxalta shares.
News For BXLT;SHPG From the Last 2 Days
There are no results for your query BXLT;SHPG